Neurotech International Past Earnings Performance
Past criteria checks 0/6
Neurotech International's earnings have been declining at an average annual rate of -10.5%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 64.4% per year.
Key information
-10.5%
Earnings growth rate
39.7%
EPS growth rate
| Medical Equipment Industry Growth | 5.8% |
| Revenue growth rate | 64.4% |
| Return on equity | -103.9% |
| Net Margin | -155.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Neurotech International makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 3 | -5 | 2 | 6 |
| 30 Sep 23 | 2 | -6 | 2 | 6 |
| 30 Jun 23 | 1 | -8 | 3 | 6 |
| 31 Mar 23 | 1 | -6 | 3 | 5 |
| 31 Dec 22 | 2 | -5 | 3 | 3 |
| 30 Sep 22 | 1 | -4 | 2 | 3 |
| 30 Jun 22 | 1 | -3 | 1 | 3 |
| 31 Mar 22 | 0 | -4 | 2 | 4 |
| 31 Dec 21 | 0 | -6 | 2 | 5 |
| 30 Sep 21 | 0 | -7 | 2 | 5 |
| 30 Jun 21 | 0 | -7 | 2 | 5 |
| 31 Mar 21 | 0 | -6 | 2 | 3 |
| 31 Dec 20 | 0 | -5 | 2 | 0 |
| 30 Sep 20 | 0 | -3 | 1 | 0 |
| 30 Jun 20 | 0 | -2 | 1 | 0 |
| 31 Mar 20 | 0 | -3 | 1 | 0 |
| 31 Dec 19 | 0 | -4 | 2 | 0 |
| 30 Sep 19 | 0 | -4 | 2 | 0 |
| 30 Jun 19 | 0 | -5 | 2 | 0 |
| 31 Mar 19 | 0 | -4 | 2 | 0 |
| 31 Dec 18 | 0 | -4 | 3 | 0 |
| 30 Sep 18 | 0 | -4 | 3 | 0 |
| 30 Jun 18 | 0 | -4 | 3 | 0 |
| 31 Mar 18 | 0 | -4 | 3 | 0 |
| 31 Dec 17 | 0 | -4 | 3 | 0 |
| 30 Sep 17 | 0 | -4 | 3 | 0 |
| 30 Jun 17 | 0 | -4 | 3 | 0 |
| 31 Dec 16 | 0 | -4 | 3 | 0 |
| 30 Sep 16 | 0 | -4 | 3 | 0 |
| 30 Jun 16 | 0 | -3 | 2 | 0 |
| 31 Dec 15 | 0 | -1 | 1 | 0 |
Quality Earnings: NTI is currently unprofitable.
Growing Profit Margin: NTI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NTI is unprofitable, and losses have increased over the past 5 years at a rate of 10.5% per year.
Accelerating Growth: Unable to compare NTI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NTI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Return on Equity
High ROE: NTI has a negative Return on Equity (-103.92%), as it is currently unprofitable.